Contineum initiated with an Outperform at William Blair
Confident Investing Starts Here:
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CBS News
17 hours ago
- CBS News
Pipe Unlocks Financial Growth for SMBs with Embedded Capital Access
This content was provided by Acumen Media for Pipe. This advertiser content was paid for and created by Acumen. Neither CBS News nor CBS News Brand Studio, the brand marketing arm of CBS News, were involved in the creation of this content. Small and medium-sized businesses are the backbone of the American economy, contributing 43.5% of the U.S. GDP and employing over 59 million workers. Yet despite their impact, access to capital remains one of their biggest challenges. Traditional lending options are often rigid and inaccessible, requiring lengthy applications, credit checks and personal guarantees. As an emerging innovator in fintech, Pipe is changing that by reshaping how these SMBs access financing by embedding it directly into the software platforms that they already use. By meeting entrepreneurs where they are, inside the tools they trust, Pipe eliminates the friction of traditional financing, opening up new opportunities for entrepreneurs to grow and thrive. For Brooke Hill and Zanbria Asante, cofounders of Swella Braid Bar, the shortcomings of traditional financing were familiar. After launching their first location in Atlanta, Georgia, they sought out capital to fuel a second opening in Charlotte, North Carolina. However, they found that traditional lending didn't exactly meet their needs: banks wanted financial statements, tax returns and personal guarantees. Then came an unexpected solution, right from the platform they already used to run their day-to-day operations. Boulevard, a client experience platform tailor-made for self-care businesses, had long been central to Swella's operations. From online booking to payment processing, Boulevard says it helps streamline their customer interactions and has become a trusted partner in their success. So when Hill received a capital offer from Boulevard, she felt confident accepting the funding. The offer, powered by Pipe, was based on Swella's real-time business performance and cash flow. With just a few clicks, Swella secured the capital they needed—no paperwork, credit scores or collateral needed. The embedded finance market is growing rapidly, projected to exceed $588 billion in revenue by 2030, according to Bain & Company, with embedded lending emerging as a key driver of this growth. By partnering with Pipe, companies like Boulevard are offering their customers not only business tools but also direct access to customer-friendly capital at the point of need. Under the leadership of CEO Luke Voiles, Pipe is transforming the financial landscape by making capital more accessible, seamless and aligned with the way these small businesses operate today.
Yahoo
3 days ago
- Yahoo
William Blair Remains Bullish on Genmab A/S (GMAB)
Genmab A/S (NASDAQ:GMAB) is one of the top most undervalued biotech stocks to buy now. On August 7, William Blair analyst Matt Phipps reiterated a bullish stance on Genmab A/S (NASDAQ:GMAB), giving the stock a Buy rating without assigning a price target. A scientist in a lab using a microscope to develop new treatments for Multiple Myeloma. The analyst supported the rating with the company's solid financial performance and promising pipeline developments, stating that Genmab A/S (NASDAQ:GMAB) surpassed both consensus and internal revenue estimates, reporting strong fiscal Q2 results. He attributed the growth to a notable sales growth of Epkinly and robust royalties from Darzalex and Kesimpta. The company's financial strength prompted an upward revision of the full-year revenue guidance, suggesting increased confidence in solid performance by Genmab A/S (NASDAQ:GMAB), the analyst added. Genmab A/S (NASDAQ:GMAB) is an international biotechnology company that develops human antibody therapeutics for the treatment of cancer and other diseases. Its product pipeline includes DARZALEX to treat certain indications of multiple myeloma, TEPEZZA for the treatment of thyroid eye disease, and Arzerra to treat certain indications of chronic lymphocytic leukemia. While we acknowledge the potential of GMAB as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.
Yahoo
3 days ago
- Yahoo
William Blair Maintained a Buy Rating on TTEC Holdings (TTEC)
TTEC Holdings, Inc. (NASDAQ:TTEC) is one of the . On August 8, William Blair analyst Maggie Nolan maintained a Buy rating on TTEC Holdings, Inc. (NASDAQ:TTEC), without disclosing any price target. The analyst reiterated his bullish sentiment following the company's fiscal second quarter 2025 earnings release. Nolan noted that the company exceeded revenue expectations despite a slight 3.8% year-over-year decrease. The company posted a revenue of $513.57 million, which exceeded expectations by $17.64 million. Moreover, TTEC Holdings, Inc. (NASDAQ:TTEC) demonstrated solid growth, particularly in its embedded customer base within the Engage segment. The segment showed a decline but outperformed estimates, driven by AI-driven solutions that improved client retention and growth. A business executive reviewing customer analytics on their laptop in a modern office. In addition, Nolan also highlighted the company's cost optimization strategies that led to better operating margins across both its segments. Looking ahead, management raised its full-year outlook and now expects revenue in the range of $2.06 billion to $2.11 billion. TTEC Holdings, Inc. (NASDAQ:TTEC) provides customer experience technology and services, using artificial intelligence. It operates through two main segments, including the Digital and Engage segments. While we acknowledge the potential of TTEC as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
